Go Pro
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Geron Corporation stock logo
GERN
Geron
$1.52
-1.9%		$1.42
$1.04
▼
$2.01
$976.56M0.6111.41 million shs4.43 million shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Geron Corporation stock logo
GERN
Geron
0.00%+3.40%+4.83%+18.75%+9.35%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Geron Corporation stock logo
GERN
Geron
$1.52
-1.9%		$1.42
$1.04
▼
$2.01
$976.56M0.6111.41 million shs4.43 million shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Geron Corporation stock logo
GERN
Geron
0.00%+3.40%+4.83%+18.75%+9.35%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Geron Corporation stock logo
GERN
Geron
2.20
Hold$4.00163.16% Upside

Current Analyst Ratings Breakdown

Latest GERN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/11/2026
Geron Corporation stock logo
GERN
Geron
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/24/2026
Geron Corporation stock logo
GERN
Geron
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
7/9/2026
Geron Corporation stock logo
GERN
Geron
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
6/23/2026
Geron Corporation stock logo
GERN
Geron
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
5/26/2026
Geron Corporation stock logo
GERN
Geron
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
(Data available from 8/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Geron Corporation stock logo
GERN
Geron
$183.88M5.31N/AN/A$0.34 per share4.47
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Geron Corporation stock logo
GERN
Geron
-$83.50M-$0.11N/A25.33N/A-34.17%-24.48%-10.30%11/4/2026 (Estimated)

Latest GERN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2026Q2 2026
Geron Corporation stock logo
GERN
Geron
-$0.0089-$0.02-$0.0111-$0.02$55.30 million$57.48 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Geron Corporation stock logo
GERN
Geron
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Geron Corporation stock logo
GERN
Geron
0.55
6.91
5.16

Institutional Ownership

CompanyInstitutional Ownership
Geron Corporation stock logo
GERN
Geron
73.71%

Insider Ownership

CompanyInsider Ownership
Geron Corporation stock logo
GERN
Geron
1.71%
CompanyEmployeesShares OutstandingFree FloatOptionable
Geron Corporation stock logo
GERN
Geron
70642.47 million631.49 millionOptionable

Recent News About These Companies

Edmond DE Rothschild Holding S.A. Buys New Holdings in Geron Corporation $GERN
August 21 at 4:15 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-edmond-de-rothschild-holding-sa-buys-new-holdings-in-geron-corporation-gern-2026-08-21/
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 18, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/18/3347218/35501/en/geron-corporation-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html
Geron Corp.: Management's Plan Taking Shape As Competition Heats Up In Myelofibrosis
August 18, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4937704-geron-corp-managements-plan-taking-shape?utm_source=marketbeat.com&utm_medium=referral&feed_item_type=article?source=MarketBeat
Geron’s RYTELO Drives Revenue as Trial Risks Linger
August 16, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/gerons-rytelo-drives-revenue-as-trial-risks-linger?utm_source=marketbeat.com&utm_medium=referral
Geron (NASDAQ:GERN) Stock Price Down 5.2% - Here's Why
August 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/geron-nasdaqgern-stock-price-down-52-heres-why-2026-08-14/
Geron (NASDAQ:GERN) Shares Up 6.4% - Here's What Happened
August 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/geron-nasdaqgern-shares-up-64-heres-what-happened-2026-08-11/
Geron Corporation $GERN Stake Raised by Renaissance Technologies LLC
August 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-geron-corporation-gern-stake-raised-by-renaissance-technologies-llc-2026-08-10/
Geron (GERN) Is Up 14.7% After Issuing First RYTELO Revenue Guide And Narrowing Losses - Has The Bull Case Changed?
August 9, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/geron-gern-14-7-issuing-071513251.html
Geron (GERN) Back In Focus As Fresh Guidance And Earnings Test Its Undervalued Narrative
August 9, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/geron-gern-back-focus-fresh-081109079.html
Geron Corporation Stock (GERN) Opinions on Recent Price Surge and Trial Updates
August 8, 2026  |  quiverquant.comQ
Wedbush Remains a Buy on Geron (GERN)
August 8, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/GERN/pressreleases/3719225/wedbush-remains-a-buy-on-geron-gern/
Janus Henderson Group PLC Raises Position in Geron Corporation $GERN
August 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-janus-henderson-group-plc-raises-position-in-geron-corporation-gern-2026-08-08/
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Geron (GERN), Zimmer Biomet Holdings (ZBH) and Recursion Pharmaceuticals (RXRX)
August 7, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/ZBH/pressreleases/3700511/analysts-opinions-are-mixed-on-these-healthcare-stocks-geron-gern-zimmer-biomet-holdings-zbh-and-recursion-pharmaceuticals-rxrx/
HC Wainwright Issues Pessimistic Forecast for Geron Earnings
August 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/hc-wainwright-issues-pessimistic-forecast-for-geron-earnings-2026-08-07/
Geron (GERN) Q2 2026 Earnings Call Transcript
August 6, 2026  |  aol.comA
Research Analysts Issue Forecasts for Geron Q4 Earnings
August 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/research-analysts-issue-forecasts-for-geron-q4-earnings-2026-08-06/
Geron: Q2 Earnings Snapshot
August 5, 2026  |  aol.comA
Geron adds a record 16% as Rytelo drives Q2 revenue beat
August 5, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4626141-geron-stock-gains-q2-revenue-beat
Geron (NASDAQ:GERN) Posts Earnings Results, Misses Expectations By $0.01 EPS
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/geron-nasdaqgern-posts-earnings-results-misses-expectations-by-001-eps-2026-08-05/
Geron (NASDAQ:GERN) Trading Up 16.4% - Time to Buy?
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/geron-nasdaqgern-trading-up-164-time-to-buy-2026-08-05/
Investors Purchase Large Volume of Geron Call Options (NASDAQ:GERN)
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/investors-purchase-large-volume-of-geron-call-options-nasdaqgern-2026-08-05/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Geron stock logo

Geron NASDAQ:GERN

$1.52 -0.03 (-1.94%)
As of 08/21/2026 04:00 PM Eastern

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas